Aficamten (5 mg, 10 mg, 15 mg, and 20 mg)

Drug identity checked against registry records

Also recorded as CK-3773274

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCMNCT05186818CytokineticsPhase 3Completed2023-11-10Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.